D-Index & Metrics Best Publications
Malaz Boustani

Malaz Boustani

Indiana University
United States

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Disease

His scientific interests lie mostly in Dementia, Psychiatry, Gerontology, Delirium and Physical therapy. Malaz Boustani has included themes like Odds ratio, Anticholinergic, Cognition, Confidence interval and Comorbidity in his Dementia study. In the field of Psychiatry, his study on Geriatrics, Depression, Cognitive disorder and DSM-5 overlaps with subjects such as Differential diagnosis.

His Gerontology research is multidisciplinary, incorporating perspectives in Cohort study, Quality of life, Long-term care, Disease and Public health. His study with Delirium involves better knowledge in Intensive care medicine. His Physical therapy research includes themes of Psychological intervention, CINAHL, Physical medicine and rehabilitation, Randomized controlled trial and PsycINFO.

His most cited work include:

  • Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. (611 citations)
  • Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. (464 citations)
  • Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study (390 citations)

What are the main themes of his work throughout his whole career to date?

Dementia, Gerontology, Psychiatry, Delirium and Randomized controlled trial are his primary areas of study. His research in Dementia intersects with topics in Anticholinergic, Cognition and Primary care. Malaz Boustani combines subjects such as Odds ratio and Cohort study with his study of Anticholinergic.

His study on Gerontology also encompasses disciplines like

  • Cognitive impairment which intersects with area such as Risk factor,

  • Cross-sectional study which is related to area like Geriatrics. His Delirium study also includes

  • Intensive care unit that connect with fields like Mechanical ventilation,

  • Emergency medicine and related Retrospective cohort study and Prospective cohort study. As part of the same scientific family, he usually focuses on Randomized controlled trial, concentrating on Physical therapy and intersecting with Clinical trial and Psychological intervention.

He most often published in these fields:

  • Dementia (66.35%)
  • Gerontology (30.57%)
  • Psychiatry (31.28%)

What were the highlights of his more recent work (between 2017-2021)?

  • Dementia (66.35%)
  • Delirium (24.17%)
  • Randomized controlled trial (23.70%)

In recent papers he was focusing on the following fields of study:

Dementia, Delirium, Randomized controlled trial, Anticholinergic and Intensive care unit are his primary areas of study. His work carried out in the field of Dementia brings together such families of science as Odds ratio, Gerontology and Pediatrics. His Delirium study combines topics from a wide range of disciplines, such as Incidence, Intensive care, Coma, Emergency medicine and Critically ill.

Malaz Boustani has researched Randomized controlled trial in several fields, including Cognitive training, Clinical trial, Collaborative Care, Quality of life and Physical therapy. His research on Anticholinergic also deals with topics like

  • Cohort study which connect with Pharmacy,
  • Cognition that connect with fields like Psychological intervention,
  • Alzheimer's disease that connect with fields like Anticholinergic agents. His study in Intensive care unit is interdisciplinary in nature, drawing from both Interquartile range and Randomization.

Between 2017 and 2021, his most popular works were:

  • Anticholinergic drugs and risk of dementia : case-control study (160 citations)
  • Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care (30 citations)
  • Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care (30 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Psychiatry

Malaz Boustani spends much of his time researching Dementia, Delirium, Anticholinergic, Randomized controlled trial and Cognition. The concepts of his Dementia study are interwoven with issues in Odds ratio, Case-control study, Confidence interval, Alzheimer's disease and Pediatrics. Malaz Boustani interconnects Poisson regression, Reimbursement and Gerontology in the investigation of issues within Alzheimer's disease.

His Delirium research includes elements of Patient admissions, Emergency medicine, Intensive care, Intensive care unit and Critically ill. His Randomized controlled trial study incorporates themes from Cognitive training, Interquartile range, Quality of life and Clinical trial. Cognition is a primary field of his research addressed under Psychiatry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial.

Christopher M. Callahan;Malaz A. Boustani;Frederick W. Unverzagt;Mary G. Austrom.
JAMA (2006)

920 Citations

Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force.

Malaz Boustani;Britt Peterson;Laura Hanson;Russell Harris.
Annals of Internal Medicine (2003)

809 Citations

Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study

Chris Fox;Kathryn Richardson;Ian D. Maidment;Ian D. Maidment;George M. Savva.
Journal of the American Geriatrics Society (2011)

630 Citations

The Public Health Impact of Alzheimer's Disease, 2000–2050: Potential Implication of Treatment Advances

Philip D. Sloane;Sheryl Zimmerman;Chirayath Suchindran;Peter Reed.
Annual Review of Public Health (2002)

549 Citations

Impact of anticholinergics on the aging brain: a review and practical application

Malaz Boustani;Noll Campbell;Stephanie Munger;Stephanie Munger;Ian Maidment.
Aging Health (2008)

549 Citations

The cognitive impact of anticholinergics: a clinical review.

Noll Campbell;Malaz Boustani;Tony Limbil;Carol Ott.
Clinical Interventions in Aging (2009)

487 Citations

Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting

Cyndy B. Cordell;Soo Borson;Malaz Boustani;Malaz Boustani;Joshua Chodosh;Joshua Chodosh.
Alzheimers & Dementia (2013)

486 Citations

Attitudes, Stress, and Satisfaction of Staff Who Care for Residents With Dementia

Sheryl Zimmerman;Christianna S. Williams;Peter S. Reed;Malaz Boustani.
Gerontologist (2005)

429 Citations

Implementing a screening and diagnosis program for dementia in primary care.

Malaz Boustani;Christopher M. Callahan;Christopher M. Callahan;Frederick W. Unverzagt;Mary G. Austrom.
Journal of General Internal Medicine (2005)

366 Citations

American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults

Mary Samuel;Sharon K. Inouye;Tom Robinson;Caroline Blaum.
Journal of the American Geriatrics Society (2015)

366 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Malaz Boustani

E. Wesley Ely

E. Wesley Ely

Vanderbilt University Medical Center

Publications: 59

Sharon K. Inouye

Sharon K. Inouye

Harvard Medical School

Publications: 45

Christopher M. Callahan

Christopher M. Callahan

Indiana University

Publications: 41

Carol Brayne

Carol Brayne

University of Cambridge

Publications: 41

Sheryl Zimmerman

Sheryl Zimmerman

University of North Carolina at Chapel Hill

Publications: 37

John E. Morley

John E. Morley

Saint Louis University

Publications: 31

Steve Iliffe

Steve Iliffe

University College London

Publications: 31

Sarah N. Hilmer

Sarah N. Hilmer

Royal North Shore Hospital

Publications: 31

Constantine G. Lyketsos

Constantine G. Lyketsos

Johns Hopkins University

Publications: 29

David B. Reuben

David B. Reuben

University of California, Los Angeles

Publications: 29

Gill Livingston

Gill Livingston

University College London

Publications: 26

Bruno Vellas

Bruno Vellas

Federal University of Toulouse Midi-Pyrénées

Publications: 26

Nathan Herrmann

Nathan Herrmann

Sunnybrook Health Science Centre

Publications: 25

Edward R. Marcantonio

Edward R. Marcantonio

Beth Israel Deaconess Medical Center

Publications: 25

Clive Ballard

Clive Ballard

University of Exeter

Publications: 25

Henry Brodaty

Henry Brodaty

University of New South Wales

Publications: 23

Trending Scientists

Wilbur G. Lewellen

Wilbur G. Lewellen

Purdue University West Lafayette

Mostafa Abbaszadeh

Mostafa Abbaszadeh

Amirkabir University of Technology

Hui Jing

Hui Jing

Hunan Normal University

Marie-Claire Bellissent-Funel

Marie-Claire Bellissent-Funel

University of Paris-Saclay

Joel M. Harris

Joel M. Harris

University of Utah

Wesley A. Henderson

Wesley A. Henderson

United States Army Research Laboratory

Longtao Ma

Longtao Ma

City University of Hong Kong

Joshua D. Smith

Joshua D. Smith

University of Washington

Georg Umgiesser

Georg Umgiesser

National Academies of Sciences, Engineering, and Medicine

Violette Geissen

Violette Geissen

Wageningen University & Research

Frederic Dick

Frederic Dick

Birkbeck, University of London

Stuart R. Steinhauer

Stuart R. Steinhauer

VA Pittsburgh Healthcare System

Nour Sneige

Nour Sneige

The University of Texas MD Anderson Cancer Center

Göran Pershagen

Göran Pershagen

Karolinska Institute

Paul Zimmet

Paul Zimmet

Monash University

Something went wrong. Please try again later.